| Date | Title | Description | |
|---|---|---|---|
| 26 Jul 2023 | On buy-back programmes | The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program. | Download |
| 26 Jul 2023 | On P&L | The Company releases the press release related to the first half 2023 financial results | Download |
| 10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
| 10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
| 25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 27 Jul 2022 | On business and financial situation | The Company releases the press release related to the first half 2022 financial results | Download |
| 27 Jul 2022 | On business and financial situation | The Company releases the first half 2022 financial results presentation | Download |
| 04 Jul 2022 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the second quarter of 2022 | Download |
| 30 Jun 2022 | Other relevant information | The Company informs about the dividends payment | Download |
| 16 Jun 2022 | Other relevant information | The Company has agreed to execute the capital reduction approved by the 2022 Ordinary General Meeting to amortize the shares acquired in the framework of the own shares repurchase programs | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 08 Nov 2012 | Composición Consejo de Administración | Download | |
| 18 Sep 2012 | Otros sobre negocio y situación financiera | Download | |
| 26 Jul 2012 | Información sobre resultados (2) | Download | |
| 26 Jul 2012 | Información sobre resultados | Download | |
| 26 Jul 2012 | Información financiera intermedia | Download |